Review




Structured Review

CH Instruments parametric pearson chi square tests
Parametric Pearson Chi Square Tests, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parametric pearson chi square tests/product/CH Instruments
Average 90 stars, based on 1 article reviews
parametric pearson chi square tests - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
CH Instruments parametric pearson chi square tests
Parametric Pearson Chi Square Tests, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parametric pearson chi square tests/product/CH Instruments
Average 90 stars, based on 1 article reviews
parametric pearson chi square tests - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments non-parametric pearson chi-square test
Non Parametric Pearson Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-parametric pearson chi-square test/product/CH Instruments
Average 90 stars, based on 1 article reviews
non-parametric pearson chi-square test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments non-parametric pearson’s chi-squared test
Non Parametric Pearson’s Chi Squared Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-parametric pearson’s chi-squared test/product/CH Instruments
Average 90 stars, based on 1 article reviews
non-parametric pearson’s chi-squared test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments non-parametric pearson’s chi-square test
Non Parametric Pearson’s Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-parametric pearson’s chi-square test/product/CH Instruments
Average 90 stars, based on 1 article reviews
non-parametric pearson’s chi-square test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments non-parametric pearson chi-squared test
Non Parametric Pearson Chi Squared Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-parametric pearson chi-squared test/product/CH Instruments
Average 90 stars, based on 1 article reviews
non-parametric pearson chi-squared test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments parametric pearson's chi-squared test
Parametric Pearson's Chi Squared Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parametric pearson's chi-squared test/product/CH Instruments
Average 90 stars, based on 1 article reviews
parametric pearson's chi-squared test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments parametric pearson’s chi-square test
AKT activation correlates with p53 mutation in triple-negative breast cancers of obese patients. (A) Immunostaining with antibodies against p53 and p-AKT S473 of representative triple-negative breast cancer sections derived from obese and nonobese patients. H, hematoxylin staining. (Scale bars: 100 μm.) (B) Graphs summarize p-AKT S473 staining in tumor samples from 32 obese patients [body mass index (BMI) > 30] and 20 nonobese patients, sorted according to p53 status. The horizontal bar indicates the median. Correlations were analyzed by a nonparametric Mann–Whitney U test. (C) Table summarizes the same tumor samples as in B, grouped according to p53 status and p-AKT S473 staining. Tumors with p53 staining >80% have been classified as mutant p53. Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric <t>Pearson’s</t> chi-square test (P-val). (D) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP.
Parametric Pearson’s Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/parametric pearson’s chi-square test/product/CH Instruments
Average 90 stars, based on 1 article reviews
parametric pearson’s chi-square test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


AKT activation correlates with p53 mutation in triple-negative breast cancers of obese patients. (A) Immunostaining with antibodies against p53 and p-AKT S473 of representative triple-negative breast cancer sections derived from obese and nonobese patients. H, hematoxylin staining. (Scale bars: 100 μm.) (B) Graphs summarize p-AKT S473 staining in tumor samples from 32 obese patients [body mass index (BMI) > 30] and 20 nonobese patients, sorted according to p53 status. The horizontal bar indicates the median. Correlations were analyzed by a nonparametric Mann–Whitney U test. (C) Table summarizes the same tumor samples as in B, grouped according to p53 status and p-AKT S473 staining. Tumors with p53 staining >80% have been classified as mutant p53. Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). (D) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP

doi: 10.1073/pnas.1700996114

Figure Lengend Snippet: AKT activation correlates with p53 mutation in triple-negative breast cancers of obese patients. (A) Immunostaining with antibodies against p53 and p-AKT S473 of representative triple-negative breast cancer sections derived from obese and nonobese patients. H, hematoxylin staining. (Scale bars: 100 μm.) (B) Graphs summarize p-AKT S473 staining in tumor samples from 32 obese patients [body mass index (BMI) > 30] and 20 nonobese patients, sorted according to p53 status. The horizontal bar indicates the median. Correlations were analyzed by a nonparametric Mann–Whitney U test. (C) Table summarizes the same tumor samples as in B, grouped according to p53 status and p-AKT S473 staining. Tumors with p53 staining >80% have been classified as mutant p53. Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). (D) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP.

Article Snippet: Tumors with p-AKT staining >15% have been classified as “positive.” Correlations were analyzed by a parametric Pearson’s chi-square test (P-val). ( D ) Proposed model for the gain of function of mutant p53 in the response to insulin as mediated by its cytoplasmic interaction with DAB2IP.

Techniques: Activation Assay, Mutagenesis, Immunostaining, Derivative Assay, Staining, MANN-WHITNEY